Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor

NCT: NCT06858826 · COMPLETED

NCT IDNCT06858826
StatusCOMPLETED
Start Date2025-03-10
Completion2025-07-01
SponsorAdvanced Bionics (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective within-subjects repeated-measures study that will enroll 18 bilateral adult users implanted with a HiResolution Bionic Ear System (HiRes 90KTM, HiRes 90K TM Advantage, HiResTM Ultra, HiResTM Ultra 3D and CII with HiFocus electrode).

Frequently Asked Questions

What is Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor?

Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor is a clinical trial registered under NCT06858826. Current status: COMPLETED.

What is the status of NCT06858826?

The current status of NCT06858826 (Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor) is: COMPLETED.

When did Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor start?

Lumity CI Study - Clinical Evaluation of Next Generation Cochlear Implant Sound Processor started on 2025-03-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑